Inclisiran Approval Held Up by Inspection-Related Issues
Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.
Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.
Beta-blocker pharmacokinetics comparison chart for hypertension.
A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension.
A comparative list of combination antihypertensive medications.
A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Management of hypertension in adults based on evidence-based guidelines.
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.